XML 68 R4.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Consolidated Statements of Operations (USD $) | 3 Months Ended | 12 Months Ended
--- | --- | ---
Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012
Revenues: |  |  |  |  |  |  |  |  |  |  |
Revenue under collaborative research and development arrangements | $ 1,758,108 ino_RevenueUnderCollaborativeResearchandDevelopmentArrangements | $ 1,114,952 ino_RevenueUnderCollaborativeResearchandDevelopmentArrangements | $ 3,107,781 ino_RevenueUnderCollaborativeResearchandDevelopmentArrangements | $ 1,435,727 ino_RevenueUnderCollaborativeResearchandDevelopmentArrangements | $ 822,217 ino_RevenueUnderCollaborativeResearchandDevelopmentArrangements | $ 8,388,760 ino_RevenueUnderCollaborativeResearchandDevelopmentArrangements | $ 14,311 ino_RevenueUnderCollaborativeResearchandDevelopmentArrangements | $ 14,259 ino_RevenueUnderCollaborativeResearchandDevelopmentArrangements | $ 7,416,568 ino_RevenueUnderCollaborativeResearchandDevelopmentArrangements | $ 9,239,547 ino_RevenueUnderCollaborativeResearchandDevelopmentArrangements | $ 82,536 ino_RevenueUnderCollaborativeResearchandDevelopmentArrangements
Revenue under collaborative research and development arrangements with affiliated entity | 112,500 ino_RevenueUnderCollaborativeResearchAndDevelopmentArrangementsWithAffiliatedEntity | 112,500 ino_RevenueUnderCollaborativeResearchAndDevelopmentArrangementsWithAffiliatedEntity | 137,500 ino_RevenueUnderCollaborativeResearchAndDevelopmentArrangementsWithAffiliatedEntity | 116,964 ino_RevenueUnderCollaborativeResearchAndDevelopmentArrangementsWithAffiliatedEntity | 106,250 ino_RevenueUnderCollaborativeResearchAndDevelopmentArrangementsWithAffiliatedEntity | 106,250 ino_RevenueUnderCollaborativeResearchAndDevelopmentArrangementsWithAffiliatedEntity | 106,250 ino_RevenueUnderCollaborativeResearchAndDevelopmentArrangementsWithAffiliatedEntity | 106,250 ino_RevenueUnderCollaborativeResearchAndDevelopmentArrangementsWithAffiliatedEntity | 479,464 ino_RevenueUnderCollaborativeResearchAndDevelopmentArrangementsWithAffiliatedEntity | 425,000 ino_RevenueUnderCollaborativeResearchAndDevelopmentArrangementsWithAffiliatedEntity | 577,467 ino_RevenueUnderCollaborativeResearchAndDevelopmentArrangementsWithAffiliatedEntity
Grants and miscellaneous revenue | 586,500 us-gaap_RevenueFromGrants | 612,901 us-gaap_RevenueFromGrants | 556,381 us-gaap_RevenueFromGrants | 804,952 us-gaap_RevenueFromGrants | 811,199 us-gaap_RevenueFromGrants | 991,835 us-gaap_RevenueFromGrants | 665,049 us-gaap_RevenueFromGrants | 1,334,716 us-gaap_RevenueFromGrants | 2,560,734 us-gaap_RevenueFromGrants | 3,802,799 us-gaap_RevenueFromGrants | 3,458,649 us-gaap_RevenueFromGrants
Total revenues | 2,457,108 us-gaap_Revenues | 1,840,353 us-gaap_Revenues | 3,801,662 us-gaap_Revenues | 2,357,643 us-gaap_Revenues | 1,739,666 us-gaap_Revenues | 9,486,845 us-gaap_Revenues | 785,610 us-gaap_Revenues | 1,455,225 us-gaap_Revenues | 10,456,766 us-gaap_Revenues | 13,467,346 us-gaap_Revenues | 4,118,652 us-gaap_Revenues
Operating expenses: |  |  |  |  |  |  |  |  |  |  |
Research and development | 9,244,473 us-gaap_ResearchAndDevelopmentExpense | 7,017,805 us-gaap_ResearchAndDevelopmentExpense | 9,607,281 us-gaap_ResearchAndDevelopmentExpense | 8,225,480 us-gaap_ResearchAndDevelopmentExpense | 6,404,005 us-gaap_ResearchAndDevelopmentExpense | 5,438,405 us-gaap_ResearchAndDevelopmentExpense | 4,411,082 us-gaap_ResearchAndDevelopmentExpense | 5,115,112 us-gaap_ResearchAndDevelopmentExpense | 34,095,039 us-gaap_ResearchAndDevelopmentExpense | 21,368,604 us-gaap_ResearchAndDevelopmentExpense | 17,984,825 us-gaap_ResearchAndDevelopmentExpense
General and administrative | 4,224,429 us-gaap_GeneralAndAdministrativeExpense | 3,153,714 us-gaap_GeneralAndAdministrativeExpense | 4,347,327 us-gaap_GeneralAndAdministrativeExpense | 4,132,218 us-gaap_GeneralAndAdministrativeExpense | 4,339,539 us-gaap_GeneralAndAdministrativeExpense | 3,282,796 us-gaap_GeneralAndAdministrativeExpense | 3,046,586 us-gaap_GeneralAndAdministrativeExpense | 2,974,153 us-gaap_GeneralAndAdministrativeExpense | 15,857,688 us-gaap_GeneralAndAdministrativeExpense | 13,643,074 us-gaap_GeneralAndAdministrativeExpense | 10,778,359 us-gaap_GeneralAndAdministrativeExpense
Gain on sale of intangible assets |  |  |  |  | (1,000,000)us-gaap_GainLossOnDispositionOfIntangibleAssets | 0 us-gaap_GainLossOnDispositionOfIntangibleAssets | (1,000,000)us-gaap_GainLossOnDispositionOfIntangibleAssets | 0 us-gaap_GainLossOnDispositionOfIntangibleAssets | 0 us-gaap_GainLossOnDispositionOfIntangibleAssets | (2,000,000)us-gaap_GainLossOnDispositionOfIntangibleAssets | (1,151,000)us-gaap_GainLossOnDispositionOfIntangibleAssets
Total operating expenses | 13,468,902 us-gaap_OperatingExpenses | 10,171,519 us-gaap_OperatingExpenses | 13,954,608 us-gaap_OperatingExpenses | 12,357,698 us-gaap_OperatingExpenses | 9,743,544 us-gaap_OperatingExpenses | 8,721,201 us-gaap_OperatingExpenses | 6,457,668 us-gaap_OperatingExpenses | 8,089,265 us-gaap_OperatingExpenses | 49,952,727 us-gaap_OperatingExpenses | 33,011,678 us-gaap_OperatingExpenses | 27,612,184 us-gaap_OperatingExpenses
Loss from operations | (11,011,794)us-gaap_OperatingIncomeLoss | (8,331,166)us-gaap_OperatingIncomeLoss | (10,152,946)us-gaap_OperatingIncomeLoss | (10,000,055)us-gaap_OperatingIncomeLoss | (8,003,878)us-gaap_OperatingIncomeLoss | 765,644 us-gaap_OperatingIncomeLoss | (5,672,058)us-gaap_OperatingIncomeLoss | (6,634,040)us-gaap_OperatingIncomeLoss | (39,495,961)us-gaap_OperatingIncomeLoss | (19,544,332)us-gaap_OperatingIncomeLoss | (23,493,532)us-gaap_OperatingIncomeLoss
Other income (expense): |  |  |  |  |  |  |  |  |  |  |
Interest and other income, net | 113,212 us-gaap_InterestAndOtherIncome | 97,174 us-gaap_InterestAndOtherIncome | 68,999 us-gaap_InterestAndOtherIncome | 52,076 us-gaap_InterestAndOtherIncome | 8,576 us-gaap_InterestAndOtherIncome | 46,787 us-gaap_InterestAndOtherIncome | 37,391 us-gaap_InterestAndOtherIncome | 39,460 us-gaap_InterestAndOtherIncome | 331,461 us-gaap_InterestAndOtherIncome | 132,214 us-gaap_InterestAndOtherIncome | 166,113 us-gaap_InterestAndOtherIncome
Change in fair value of common stock warrants | 143,659 ino_ChangeInFairValueOfCommonStockWarrants | (113,980)ino_ChangeInFairValueOfCommonStockWarrants | 824,390 ino_ChangeInFairValueOfCommonStockWarrants | (505,926)ino_ChangeInFairValueOfCommonStockWarrants | (6,052,965)ino_ChangeInFairValueOfCommonStockWarrants | (34,952,210)ino_ChangeInFairValueOfCommonStockWarrants | (3,199,878)ino_ChangeInFairValueOfCommonStockWarrants | (1,427,616)ino_ChangeInFairValueOfCommonStockWarrants | 348,143 ino_ChangeInFairValueOfCommonStockWarrants | (45,632,669)ino_ChangeInFairValueOfCommonStockWarrants | 1,982,620 ino_ChangeInFairValueOfCommonStockWarrants
Gain (Loss) on investment in affiliated entity | 3,342,436 ino_ChangeInValueOfInvestmentsInAffiliatedCompany | 1,168,911 ino_ChangeInValueOfInvestmentsInAffiliatedCompany | (1,458,160)ino_ChangeInValueOfInvestmentsInAffiliatedCompany | (376,963)ino_ChangeInValueOfInvestmentsInAffiliatedCompany | (1,419,536)ino_ChangeInValueOfInvestmentsInAffiliatedCompany | 3,248,926 ino_ChangeInValueOfInvestmentsInAffiliatedCompany | (2,032,051)ino_ChangeInValueOfInvestmentsInAffiliatedCompany | (836,084)ino_ChangeInValueOfInvestmentsInAffiliatedCompany | 2,676,224 ino_ChangeInValueOfInvestmentsInAffiliatedCompany | (1,038,745)ino_ChangeInValueOfInvestmentsInAffiliatedCompany | 1,631,819 ino_ChangeInValueOfInvestmentsInAffiliatedCompany
Net loss | (7,412,487)us-gaap_ProfitLoss | (7,179,061)us-gaap_ProfitLoss | (10,717,717)us-gaap_ProfitLoss | (10,830,868)us-gaap_ProfitLoss | (15,467,803)us-gaap_ProfitLoss | (30,890,853)us-gaap_ProfitLoss | (10,866,596)us-gaap_ProfitLoss | (8,858,280)us-gaap_ProfitLoss | (36,140,133)us-gaap_ProfitLoss | (66,083,532)us-gaap_ProfitLoss | (19,712,980)us-gaap_ProfitLoss
Net loss attributable to non-controlling interest | 1,083 us-gaap_NetIncomeLossAttributableToNoncontrollingInterest | 1,486 us-gaap_NetIncomeLossAttributableToNoncontrollingInterest | 6,443 us-gaap_NetIncomeLossAttributableToNoncontrollingInterest | 9,408 us-gaap_NetIncomeLossAttributableToNoncontrollingInterest | 13,473 us-gaap_NetIncomeLossAttributableToNoncontrollingInterest | 13,443 us-gaap_NetIncomeLossAttributableToNoncontrollingInterest | 14,008 us-gaap_NetIncomeLossAttributableToNoncontrollingInterest | 14,160 us-gaap_NetIncomeLossAttributableToNoncontrollingInterest | 18,420 us-gaap_NetIncomeLossAttributableToNoncontrollingInterest | 55,084 us-gaap_NetIncomeLossAttributableToNoncontrollingInterest | 44,025 us-gaap_NetIncomeLossAttributableToNoncontrollingInterest
Net loss attributable to Inovio Pharmaceuticals, Inc. | $ (7,411,404)us-gaap_NetIncomeLoss | $ (7,177,575)us-gaap_NetIncomeLoss | $ (10,711,274)us-gaap_NetIncomeLoss | $ (10,821,460)us-gaap_NetIncomeLoss | $ (15,454,330)us-gaap_NetIncomeLoss | $ (30,877,410)us-gaap_NetIncomeLoss | $ (10,852,588)us-gaap_NetIncomeLoss | $ (8,844,120)us-gaap_NetIncomeLoss | $ (36,121,713)us-gaap_NetIncomeLoss | $ (66,028,448)us-gaap_NetIncomeLoss | $ (19,668,955)us-gaap_NetIncomeLoss
Net loss per common share attributable to Inovio Pharmaceuticals, Inc. stockholders |  |  |  |  |  |  |  |  |  |  |
Basic ($ per share) | $ (0.12)us-gaap_EarningsPerShareBasic | $ (0.12)us-gaap_EarningsPerShareBasic | $ (0.18)us-gaap_EarningsPerShareBasic | $ (0.20)us-gaap_EarningsPerShareBasic | $ (0.30)us-gaap_EarningsPerShareBasic | $ (0.64)us-gaap_EarningsPerShareBasic | $ (0.24)us-gaap_EarningsPerShareBasic | $ (0.23)us-gaap_EarningsPerShareBasic | $ (0.61)us-gaap_EarningsPerShareBasic | $ (1.43)us-gaap_EarningsPerShareBasic | $ (0.58)us-gaap_EarningsPerShareBasic
Diluted ($ per share) | $ (0.12)us-gaap_EarningsPerShareDiluted | $ (0.12)us-gaap_EarningsPerShareDiluted | $ (0.19)us-gaap_EarningsPerShareDiluted | $ (0.20)us-gaap_EarningsPerShareDiluted | $ (0.30)us-gaap_EarningsPerShareDiluted | $ (0.64)us-gaap_EarningsPerShareDiluted | $ (0.24)us-gaap_EarningsPerShareDiluted | $ (0.23)us-gaap_EarningsPerShareDiluted | $ (0.64)us-gaap_EarningsPerShareDiluted | $ (1.43)us-gaap_EarningsPerShareDiluted | $ (0.58)us-gaap_EarningsPerShareDiluted
Weighted average number of common shares outstanding used in per share calculations: |  |  |  |  |  |  |  |  |  |  |
Basic (in shares) | 60,610,367 us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 60,392,911 us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 60,232,498 us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 55,159,002 us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 52,127,419 us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 47,989,039 us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 44,988,704 us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 39,038,883 us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 59,127,349 us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 46,087,773 us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 34,127,312 us-gaap_WeightedAverageNumberOfSharesOutstandingBasic
Diluted (in shares) | 60,805,871 us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding | 60,602,831 us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding | 60,474,859 us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding | 55,159,002 us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding | 52,127,419 us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding | 47,989,039 us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding | 44,988,704 us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding | 39,038,883 us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding | 59,408,252 us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding | 46,087,773 us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding | 34,127,312 us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

X
- Definition The net result for the period of the change in fair value of common stock warrants which are measured at fair value on a recurring basis. + References No definition available. + Details
Name: | ino_ChangeInFairValueOfCommonStockWarrants
Namespace Prefix: | ino_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The net result for the period of the change in fair value of the investment in affiliated entity. This investment is measured at fair value on a recurring basis. + References No definition available. + Details
Name: | ino_ChangeInValueOfInvestmentsInAffiliatedCompany
Namespace Prefix: | ino_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Revenue Under Collaborative Research and Development Arrangements + References No definition available. + Details
Name: | ino_RevenueUnderCollaborativeResearchandDevelopmentArrangements
Namespace Prefix: | ino_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Revenue under collaborative research and development arrangements with affiliated entity. + References No definition available. + Details
Name: | ino_RevenueUnderCollaborativeResearchAndDevelopmentArrangementsWithAffiliatedEntity
Namespace Prefix: | ino_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 55 -Paragraph 52 -URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.23) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 18 -Article 7 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 20 -Article 5 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 + Details
Name: | us-gaap_EarningsPerShareBasic
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 18 -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 20 -Article 5 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 + Details
Name: | us-gaap_EarningsPerShareDiluted
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of gain (loss) on sale or disposal of intangible assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.7,9) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_GainLossOnDispositionOfIntangibleAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_GeneralAndAdministrativeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business). + References No definition available. + Details
Name: | us-gaap_InterestAndOtherIncome
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 + Details
Name: | us-gaap_NetIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4J -URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686 + Details
Name: | us-gaap_NetIncomeLossAttributableToNoncontrollingInterest
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_NonoperatingIncomeExpenseAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. + References No definition available. + Details
Name: | us-gaap_OperatingExpenses
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_OperatingExpensesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The net result for the period of deducting operating expenses from operating revenues. + References No definition available. + Details
Name: | us-gaap_OperatingIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4K -URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 19 -URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569616-111683 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (a),(c) -URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4J -URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686 + Details
Name: | us-gaap_ProfitLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 985 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 730 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373 + Details
Name: | us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(e)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_RevenueFromGrants
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_RevenuesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1505-109256 + Details
Name: | us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Weighted-Average Number of Common Shares Outstanding -URI http://asc.fasb.org/extlink&oid=6528421 + Details
Name: | us-gaap_WeightedAverageNumberOfSharesOutstandingBasic
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration